MEDP logo

MEDP

Medpace Holdings Inc.

$508.52
$0.00(0.00%)
48
Overall
50
Value
18
Tech
76
Quality
How is this score calculated?
Market Cap
$15.47B
Volume
329.41K
52W Range
$250.05 - $628.92
Target Price
$506.42

Company Overview

Mkt Cap$15.47BPrice$508.52
Volume329.41KChange+0.00%
P/E Ratio38.3Open$491.08
Revenue$2.1BPrev Close$508.52
Net Income$404.4M52W Range$250.05 - $628.92
Div YieldN/ATarget$506.42
Overall48Value50
Quality76Technical18

No chart data available

About Medpace Holdings Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP), Revolution Medicines (RVMD) and Corbus Pharmaceuticals (CRBP)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medpace Holdings (MEDP – Research Report), Revolutio...

Howard Kima month ago
ABCD
1SymbolPriceChangeVol
2MEDP$508.520%329.41K
3
4
5
6

Get Medpace Holdings Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.